Emanuela Ricciotti
- Pharmacology top 0.2%
- Molecular Biology top 5%
- Biochemistry top 0.5%
- Cardiology and Cardiovascular Medicine top 2%
- Immunology top 5%
- Co-authors
- Garret A. FitzGeraldPaola PatrignaniTilo GroßerStefania TacconelliMarta L. CaponeMaria G. SciulliEllen PuréMiao Wang
- Topics
- Inflammatory mediators and NSAID effects (40 papers)Eicosanoids and Hypertension Pharmacology (16 papers)Antiplatelet Therapy and Cardiovascular Diseases (11 papers)
- Cited by
- PharmacologyBiochemistry
- Partner nations
- United StatesItalyGermany
In The Last Decade
Emanuela Ricciotti
54 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Pharmacology 2.0k
- Molecular Biology 1.8k
- Biochemistry 789
- Cardiology and Cardiovascular Medicine 767
- Immunology 652
Countries citing papers authored by Emanuela Ricciotti
This map shows the geographic impact of Emanuela Ricciotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Ricciotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Ricciotti more than expected).
Fields of papers citing papers by Emanuela Ricciotti
This network shows the impact of papers produced by Emanuela Ricciotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Ricciotti. The network helps show where Emanuela Ricciotti may publish in the future.
Co-authorship network of co-authors of Emanuela Ricciotti
This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Ricciotti. A scholar is included among the top collaborators of Emanuela Ricciotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Ricciotti. Emanuela Ricciotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 18 | |
| 3 | 4 | |
| 4 | 17 | |
| 5 | 28 | |
| 6 | 22 | |
| 7 | 25 | |
| 8 | 50 | |
| 9 | 126 | |
| 10 | 26 | |
| 11 | 39 | |
| 12 | 28 | |
| 13 | Prostaglandins and Inflammationbreakdown → | 2800 |
| 14 | 17 | |
| 15 | 14 | |
| 16 | 44 | |
| 17 | 25 | |
| 18 | 211 | |
| 19 | 42 | |
| 20 | 37 |
About Emanuela Ricciotti
Emanuela Ricciotti is a scholar working on Pharmacology, Biochemistry and Pharmacology, having authored 54 papers that have together received 5.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (40 papers), Eicosanoids and Hypertension Pharmacology (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). The work is most often cited by research in Pharmacology (2.0k citations), Biochemistry (789 citations) and Pharmacology (346 citations). Emanuela Ricciotti has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Garret A. FitzGerald, Paola Patrignani, Tilo Großer, Stefania Tacconelli, Marta L. Capone, Maria G. Sciulli, Ellen Puré, Miao Wang, Damián Maseda and Yiqun Hui. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.